We then performed a multivariate Cox regression analysis, and the immune signature constructed using HLA-DQA2, HOXA3, and SAA2 was found to act as an independent prognostic factor for glioma patients with IDH1mt, with an HR of 1.203 (Table 2). Here, HOXA3 is linked to central nervous system cancer.